BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

950 related articles for article (PubMed ID: 25398334)

  • 1. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.
    Fu Y; Sander JD; Reyon D; Cascio VM; Joung JK
    Nat Biotechnol; 2014 Mar; 32(3):279-284. PubMed ID: 24463574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing.
    Wyvekens N; Topkar VV; Khayter C; Joung JK; Tsai SQ
    Hum Gene Ther; 2015 Jul; 26(7):425-31. PubMed ID: 26068112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
    Kim D; Luk K; Wolfe SA; Kim JS
    Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving CRISPR-Cas9 On-Target Specificity.
    Jamal M; Ullah A; Ahsan M; Tyagi R; Habib Z; Rehman K
    Curr Issues Mol Biol; 2018; 26():65-80. PubMed ID: 28879857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking-Cas-interactive design of guide RNAs for CRISPR-Cas experiments for ENSEMBL genomes.
    Oliveros JC; Franch M; Tabas-Madrid D; San-León D; Montoliu L; Cubas P; Pazos F
    Nucleic Acids Res; 2016 Jul; 44(W1):W267-71. PubMed ID: 27166368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9.
    Fu BXH; Smith JD; Fuchs RT; Mabuchi M; Curcuru J; Robb GB; Fire AZ
    Nat Microbiol; 2019 May; 4(5):888-897. PubMed ID: 30833733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
    Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome Editing in Human Cells Using CRISPR/Cas Nucleases.
    Wyvekens N; Tsai SQ; Joung JK
    Curr Protoc Mol Biol; 2015 Oct; 112():31.3.1-31.3.18. PubMed ID: 26423589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize.
    Lee K; Zhang Y; Kleinstiver BP; Guo JA; Aryee MJ; Miller J; Malzahn A; Zarecor S; Lawrence-Dill CJ; Joung JK; Qi Y; Wang K
    Plant Biotechnol J; 2019 Feb; 17(2):362-372. PubMed ID: 29972722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
    Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
    Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecules for Enhancing the Precision and Safety of Genome Editing.
    Shin S; Jang S; Lim D
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells.
    Kim D; Bae S; Park J; Kim E; Kim S; Yu HR; Hwang J; Kim JI; Kim JS
    Nat Methods; 2015 Mar; 12(3):237-43, 1 p following 243. PubMed ID: 25664545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Targeted Mutagenesis via Cas9 Paired Nickases in Rice.
    Mikami M; Toki S; Endo M
    Plant Cell Physiol; 2016 May; 57(5):1058-68. PubMed ID: 26936792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and allele-specific genome editing of disease loci in human iPSCs.
    Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
    Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture.
    O'Geen H; Henry IM; Bhakta MS; Meckler JF; Segal DJ
    Nucleic Acids Res; 2015 Mar; 43(6):3389-404. PubMed ID: 25712100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.